Silvant Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DraftKings
DKNG
|
+$1.29M |
| 2 |
SentinelOne
S
|
+$1.15M |
| 3 |
Tesla
TSLA
|
+$1.08M |
| 4 |
S&P Global
SPGI
|
+$915K |
| 5 |
United Parcel Service
UPS
|
+$856K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.47M |
| 2 |
Apple
AAPL
|
+$8.37M |
| 3 |
Amazon
AMZN
|
+$5.31M |
| 4 |
Equinix
EQIX
|
+$3.27M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$3.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.93% |
| 2 | Healthcare | 14.26% |
| 3 | Consumer Discretionary | 14.14% |
| 4 | Financials | 13.68% |
| 5 | Communication Services | 12.49% |
Similar funds
Silvant Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Silvant Capital Management held 340 positions worth $560M, down 12% from $635M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Silvant Capital Management withdrew a net $79.7M in Q3 2021, closing 11 positions and reducing 106 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $2.16M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Silvant Capital Management opened a new position in SentinelOne worth $1.13M.
- Silvant Capital Management's largest Q3 2021 buy was SentinelOne: 21,028 shares worth $1.13M.
- Silvant Capital Management added most to DraftKings in Q3 2021, an estimated $1.29M increase.
- Silvant Capital Management's biggest Q3 2021 reduction was Microsoft, cutting an estimated $8.47M.
- Silvant Capital Management fully exited Vertex Pharmaceuticals in Q3 2021, selling an estimated $2.16M.
- Silvant Capital Management's ten largest holdings make up 45% of its $560M portfolio in Q3 2021.
- Silvant Capital Management opened 9 new positions and closed 11 in Q3 2021.
- Silvant Capital Management's portfolio value fell 12% quarter-over-quarter to $560M.
Based on Silvant Capital Management's 13F filing for Q3 2021, filed 8 Nov 2021.